1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 10

2 Introduction 11
2.1 Glaucoma Surgery Devices Overview 11

3 Products under Development 12
3.1 Glaucoma Surgery Devices - Pipeline Products by Stage of Development 12
3.2 Glaucoma Surgery Devices - Pipeline Products by Segment 13
3.3 Glaucoma Surgery Devices - Pipeline Products by Territory 14
3.4 Glaucoma Surgery Devices - Pipeline Products by Regulatory Path 15
3.5 Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date 16
3.6 Glaucoma Surgery Devices - Ongoing Clinical Trials 17

4 Glaucoma Surgery Devices - Pipeline Products under Development by Companies 18
4.1 Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development 18
4.2 Glaucoma Surgery Devices - Pipeline Products by Stage of Development 20

5 Glaucoma Surgery Devices Companies and Product Overview 22
5.1 Assenti, LLC Company Overview 22
5.1.1 Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.2 Camras Vision Company Overview 23
5.2.1 Camras Vision Pipeline Products & Ongoing Clinical Trials Overview 23
5.3 Ellex Medical Lasers Limited Company Overview 24
5.3.1 Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview 24
5.4 Eye Sonix Company Overview 25
5.4.1 Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 Galaxy Ophthalmics Inc Company Overview 28
5.5.1 Galaxy Ophthalmics Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.6 Geuder AG Company Overview 29
5.6.1 Geuder AG Pipeline Products & Ongoing Clinical Trials Overview 29
5.7 Glaukos Corp Company Overview 30
5.7.1 Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview 30
5.8 iSTAR Medical SA Company Overview 44
5.8.1 iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview 44
5.9 Ivantis Inc Company Overview 48
5.9.1 Ivantis Inc Pipeline Products & Ongoing Clinical Trials Overview 48
5.10 iVeena Delivery Systems Inc Company Overview 52
5.10.1 iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 52
5.11 Johns Hopkins University Company Overview 53
5.11.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 53
5.12 Kytogenics Pharmaceuticals Inc Company Overview 54
5.12.1 Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 54
5.13 Massachusetts Eye and Ear Infirmary Company Overview 55
5.13.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 55
5.14 Medtronic plc Company Overview 56
5.14.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 56
5.15 Meir Medical Center Company Overview 57
5.15.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 57
5.16 Merz Anteis SA Company Overview 58
5.16.1 Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview 58
5.17 MicroOptx, Inc. Company Overview 59
5.17.1 MicroOptx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.18 Ocumatrx Company Overview 62
5.18.1 Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview 62
5.19 OcuTherix Inc Company Overview 63
5.19.1 OcuTherix Inc Pipeline Products & Ongoing Clinical Trials Overview 63
5.20 OPKO Health Inc Company Overview 64
5.20.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 64
5.21 OptoLight Vision Technology Company Overview 65
5.21.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 65
5.22 Queen’s University Company Overview 66
5.22.1 Queen’s University Pipeline Products & Ongoing Clinical Trials Overview 66
5.23 Santen Pharmaceutical Co Ltd Company Overview 67
5.23.1 Santen Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
5.24 Sheba Medical Center Company Overview 70
5.24.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 70
5.25 Sight Sciences Inc Company Overview 71
5.25.1 Sight Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 71
5.26 SOLX Inc Company Overview 74
5.26.1 SOLX Inc Pipeline Products & Ongoing Clinical Trials Overview 74
5.27 Tel Aviv University Company Overview 75
5.27.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 75
5.28 TonoGuard Ltd. Company Overview 77
5.28.1 TonoGuard Ltd. Pipeline Products & Ongoing Clinical Trials Overview 77
5.29 University of Colorado Company Overview 78
5.29.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 78
5.30 University of Michigan Company Overview 80
5.30.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 80
5.31 University of Pennsylvania Company Overview 81
5.31.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 81
5.32 University of Rostock Company Overview 82
5.32.1 University of Rostock Pipeline Products & Ongoing Clinical Trials Overview 82
5.33 Westhouse Medical Services Plc (Inactive) Company Overview 83
5.33.1 Westhouse Medical Services Plc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 83

6 Glaucoma Surgery Devices- Recent Developments 84
6.1 Apr 16, 2018: Ellex iTrack and Ellex Glaucoma Business Third Quarter Sales Update 84
6.2 Apr 16, 2018: Ivantis Announces Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial 85
6.3 Apr 14, 2018: IDE Pivotal Trial Results for Glaukos iStent inject Show Significant Reductions in Unmedicated IOP in Glaucoma Subjects Undergoing Cataract Surgery 86
6.4 Apr 14, 2018: Glaukos Files Patent Infringement Lawsuit Against Ivantis 88
6.5 Apr 13, 2018: Alcon introduces pre-loaded delivery system for the CyPass Micro-Stent to enhance surgical experience 88
6.6 Apr 12, 2018: New Data from the HORIZON Trial of the Hydrus Microstent Shows Significantly Lower IOP and Medication Use at 24 Months in a US Patient Cohort 89
6.7 Apr 11, 2018: Multiple Surgeon Presentations to Include Glaukos Technologies at 2018 American Society of Cataract and Refractive Surgery 91
6.8 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 93
6.9 Mar 20, 2018: Iridex Receives CE Mark for Transilluminated Probe 94
6.10 Mar 12, 2018: Greater Manchester trust treats first patients outside of USA with ground-breaking device the size of an eyelash 94
6.11 Mar 08, 2018: Ocular Therapeutix Reports Fourth Quarter and Year End 2017 Financial Results and Business Update 95
6.12 Mar 01, 2018: New data on the CyPass Micro-Stent find fewer disease progression events, reduced dependence on traditional medications in glaucoma patients undergoing cataract surgery 97
6.13 Mar 01, 2018: OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results 98
6.14 Feb 28, 2018: Raysearch Laboratories: First clinic now live with RayCare 100
6.15 Feb 28, 2018: STAAR Surgical Reports Fourth Quarter and Full Year 2017 Results 101
6.16 Feb 28, 2018: Glaukos Reports Fourth Quarter and Full Year 2017 Financial Results 102
6.17 Feb 27, 2018: International Study Shows Long-Term Titrated IOP Control with 1, 2 or 3 Glaukos iStent Trabecular Micro-Bypass Stents in Open-Angle Glaucoma Patients 103
6.18 Feb 27, 2018: Ellex Medical Lasers: Release of Financial Results for Half-Year ended 31 December 2017 105
6.19 Feb 08, 2018: Glaukos iStent Trabecular Micro-Bypass Stent Reduced IOP and Lowered Medication Burden in Patients with Severe Glaucoma, According to New Study 105
6.20 Feb 05, 2018: CyPass Ushers in Exciting New Era of Glaucoma Treatment 107
6.21 Feb 05, 2018: Allergan Appoints Matthew M. Walsh As Executive Vice President and Chief Financial Officer 108
6.22 Feb 05, 2018: Ellex: Trading Update for Half-Year Ended 31 December 2017 108
6.23 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic’s Greater China Region 109
6.24 Jan 26, 2018: OPKO Health Announces Resignation Of Gregory Henderson As President Of BioReference Laboratories 110
6.25 Jan 08, 2018: Allergan Provides 2018 Preliminary Financial Outlook for Select Income Statement Categories and Other Updates at 36th Annual J. P. Morgan Conference 110
6.26 Jan 04, 2018: Sight Sciences Expands Surgical Portfolio with FDA Clearance of the OMNI Surgical System 111
6.27 Jan 03, 2018: Glaukos Submits IDE Application to FDA to Study iStent infinite Trabecular Micro-Bypass System 112

7 Appendix 197
7.1 Methodology 197
7.2 About GlobalData 200
7.3 Contact Us 200
7.4 Disclaimer 200

1.1 List of Tables
Table 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development 12
Table 2: Glaucoma Surgery Devices - Pipeline Products by Segment 13
Table 3: Glaucoma Surgery Devices - Pipeline Products by Territory 14
Table 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path 15
Table 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date 16
Table 6: Glaucoma Surgery Devices - Ongoing Clinical Trials 17
Table 7: Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development 18
Table 8: Glaucoma Surgery Devices - Pipeline Products by Stage of Development 20
Table 9: Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
Table 10: Intraocular Pressure Monitoring System - Product Status 22
Table 11: Intraocular Pressure Monitoring System - Product Description 22
Table 12: Camras Vision Pipeline Products & Ongoing Clinical Trials Overview 23
Table 13: Camras Shunt - Product Status 23
Table 14: Camras Shunt - Product Description 23
Table 15: Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview 24
Table 16: Glaucoma Device - Product Status 24
Table 17: Glaucoma Device - Product Description 24
Table 18: Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview 25
Table 19: Therapeutic Ultrasound Device - Glaucoma - Product Status 25
Table 20: Therapeutic Ultrasound Device - Glaucoma - Product Description 25
Table 21: Eye Sonix - Ongoing Clinical Trials Overview 26
Table 22: Therapeutic Ultrasound Device - Glaucoma - A Single-Center, Randomized, Double-Masked, 8-week Pilot Study Evaluating the Safety and Efficacy of the TUG Compared to Sham in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension 27
Table 23: Galaxy Ophthalmics Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 24: Titan Shunt - Product Status 28
Table 25: Titan Shunt - Product Description 28
Table 26: Geuder AG Pipeline Products & Ongoing Clinical Trials Overview 29
Table 27: Microsystem Implant - Product Status 29
Table 28: Microsystem Implant - Product Description 29
Table 29: Glaukos Corp Pipeline Products & Ongoing Clinical Trials Overview 30
Table 30: GTS400 - Product Status 30
Table 31: GTS400 - Product Description 30
Table 32: iStent Infinite - Product Status 31
Table 33: iStent Infinite - Product Description 31
Table 34: iStent inject Trabecular Micro-Bypass Stent - Product Status 31
Table 35: iStent inject Trabecular Micro-Bypass Stent - Product Description 32
Table 36: iStent SA - Product Status 32
Table 37: iStent SA - Product Description 32
Table 38: iStent Supra Suprachoroidal Micro-Bypass Stent - Product Status 33
Table 39: iStent Supra Suprachoroidal Micro-Bypass Stent - Product Description 33
Table 40: Glaukos Corp - Ongoing Clinical Trials Overview 34
Table 41: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Second Generationtrabecular Micro-bypass Stents and One Suprachoroidal Stent a Multicenter Study According to Mpg §23.B 36
Table 42: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent 36
Table 43: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects with Cataract Treated with Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent 36
Table 44: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With One Suprachoroidal Stent 37
Table 45: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective Evaluation of Open-angle Glaucoma Subjects with One Prior Trabeculectomy Treated Concurrently with One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents and a Postoperative Prostaglandin 37
Table 46: iStent Supra Suprachoroidal Micro-Bypass Stent - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Suprachoroidal Stent Model G3 in Conjunction with Cataract Surgery 37
Table 47: iStent inject Trabecular Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent 38
Table 48: iStent inject Trabecular Micro-Bypass Stent - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects with Cataract Treated with Cataract Surgery Plus One Trabecular Micro-bypass Stent and One Suprachoroidal Stent 38
Table 49: iStent inject Trabecular Micro-Bypass Stent - A Prospective Evaluation of the Second Generation iStent Inject in Open-angle Glaucoma Subjects on Two Preoperative Topical Ocular Hypotensive Medications 38
Table 50: iStent inject Trabecular Micro-Bypass Stent - A Prospective, Randomized Evaluation of Subjects with Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naive to Medical and Surgical Therapy, Treated with Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost Ophthalmic Solution 0.004% 39
Table 51: iStent inject Trabecular Micro-Bypass Stent - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction with Cataract Surgery 39
Table 52: iStent inject Trabecular Micro-Bypass Stent - A Randomized Controlled Trial of Cataract Surgery Versus Combined Cataract Surgery with Insertion of iStent Inject 39
Table 53: iStent SA - A Prospective Evaluation of Mild to Moderate Open-angle Glaucoma Subjects Treated with Second Generationtrabecular Micro-bypass Stents and One Suprachoroidal Stent a Multicenter Study According to Mpg §23.B 40
Table 54: iStent SA - A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication (Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject) 40
Table 55: iStent SA - A Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medications (One a Prostaglandin) Treated with Two Trabecular Micro-bypass Stents (iStent Inject) and a Postoperative Topical Prostaglandin 40
Table 56: iStent SA - Initial Phase of U.S. IDE Clinical Trial for Standalone Version of iStent inject 41
Table 57: iStent SA - The Effect of Glaucoma Surgery on Aqueous Dynamics in Patients with Glaucoma or Ocular Hypertension: An Observational Study 41
Table 58: iStent SA - Trabeculectomy with MMC and I Stent in Uveitic Glaucoma and POAG : Outcomes and Prognostic Factors 41
Table 59: iStent SA - US Investigational Device Exemption (IDE) Pivotal Study of iStent SA Standalone Micro-Invasive Glaucoma Surgery 42
Table 60: iStent Infinite - A Prospective, Multi-center, Single-arm Clinical Study to Evaluate the Safety and Efficacy of iStent Infinite in Refractory Glaucoma Patients 43
Table 61: iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview 44
Table 62: MINIject - Product Status 44
Table 63: MINIject - Product Description 44
Table 64: STARflo MINI - Product Status 45
Table 65: STARflo MINI - Product Description 45
Table 66: STARflo Plus Glaucoma Implant - Product Status 45
Table 67: STARflo Plus Glaucoma Implant - Product Description 45
Table 68: iSTAR Medical SA - Ongoing Clinical Trials Overview 46
Table 69: MINIject - A Prospective, Open, Multicenter Clinical Trial with One Cohort Analyzing the Efficacy and Safety of MINIject in Patients with Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications 47
Table 70: MINIject - A Prospective, Open, Multicentre Clinical Trial Analyzing the Effectiveness and Safety of MINIject 636 in Patients with Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications 47
Table 71: Ivantis Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 72: Hydrus Microstent - Product Status 48
Table 73: Hydrus Microstent - Product Description 48
Table 74: Ivantis Inc - Ongoing Clinical Trials Overview 49
Table 75: Hydrus Microstent - A Prospective, Multicenter, Randomized Comparison of the Hydrus Microstent to the iStent for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery 50
Table 76: Hydrus Microstent - Evaluation of Safety and Efficacy of the Hydrus Microstent in Treatment of Patients with Advanced Glaucoma 50
Table 77: Hydrus Microstent - MIGS Versus SLT in Glaucoma Patients: Prospective Study 50
Table 78: Hydrus Microstent - The Effect of Glaucoma Surgery on Aqueous Dynamics in Patients with Glaucoma or Ocular Hypertension: An Observational Study 51
Table 79: Hydrus Microstent - The Safety and Effectiveness of the Hydrus Aqueous Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery, A Prospective, Multicenter, Randomized, Controlled Clinical Trial 51
Table 80: iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 52
Table 81: IVMED-70 - Product Status 52
Table 82: IVMED-70 - Product Description 52
Table 83: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 53
Table 84: Partially Degradable Glaucoma Stent - Product Status 53
Table 85: Partially Degradable Glaucoma Stent - Product Description 53
Table 86: Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 54
Table 87: MACC-Based Device - Glaucoma Filtering - Product Status 54
Table 88: MACC-Based Device - Glaucoma Filtering - Product Description 54
Table 89: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 55
Table 90: Pressure Relief Valve Shunt - Product Status 55
Table 91: Pressure Relief Valve Shunt - Product Description 55
Table 92: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 56
Table 93: CellPlant - Product Status 56
Table 94: CellPlant - Product Description 56
Table 95: Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 57
Table 96: Glaucoma Drainage Device - Product Status 57
Table 97: Glaucoma Drainage Device - Product Description 57
Table 98: Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview 58
Table 99: Drainage Viscoelastic Injectable Implant - Product Status 58
Table 100: Drainage Viscoelastic Injectable Implant - Product Description 58
Table 101: MicroOptx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
Table 102: Brown Glaucoma Implant (BGI) - Product Status 59
Table 103: Brown Glaucoma Implant (BGI) - Product Description 59
Table 104: MicroOptx, Inc. - Ongoing Clinical Trials Overview 60
Table 105: Brown Glaucoma Implant (BGI) - Early Feasibility Study of the Brown Glaucoma Implant in Patients with No Light Perceived 61
Table 106: Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview 62
Table 107: CaPRI Device - Product Status 62
Table 108: CaPRI Device - Product Description 62
Table 109: OcuTherix Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Table 110: Deep Wave Trabeculoplasty Device - Product Status 63
Table 111: Deep Wave Trabeculoplasty Device - Product Description 63
Table 112: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 64
Table 113: Aquashunt - Product Status 64
Table 114: Aquashunt - Product Description 64
Table 115: OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 65
Table 116: Lipshitz Macular Implant - Advanced Glaucoma - Product Status 65
Table 117: Lipshitz Macular Implant - Advanced Glaucoma - Product Description 65
Table 118: Queen’s University Pipeline Products & Ongoing Clinical Trials Overview 66
Table 119: Laser Adjustable Suture - Product Status 66
Table 120: Laser Adjustable Suture - Product Description 66
Table 121: Santen Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
Table 122: InnFocus Microshunt - Product Status 67
Table 123: InnFocus Microshunt - Product Description 67
Table 124: Santen Pharmaceutical Co Ltd - Ongoing Clinical Trials Overview 68
Table 125: InnFocus Microshunt - A Randomized Study Comparing the Safety and Efficacy of the InnFocus MicroShunt Glaucoma Drainage System to Standard Trabeculectomy In Subjects with Primary Open Angle Glaucoma 69
Table 126: Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 70
Table 127: Toroidal Glaucoma Drainage Device - Product Status 70
Table 128: Toroidal Glaucoma Drainage Device - Product Description 70
Table 129: Sight Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 71
Table 130: VISCO 360 Viscosurgical System - Primary Open Angle Glaucoma - Product Status 71
Table 131: VISCO 360 Viscosurgical System - Primary Open Angle Glaucoma - Product Description 71
Table 132: Sight Sciences Inc - Ongoing Clinical Trials Overview 72
Table 133: VISCO 360 Viscosurgical System - Primary Open Angle Glaucoma - Multi-center, Prospective, Randomized, Controlled Clinical Evaluation of the Safety and Effectiveness of the Sight Sciences VISCO360 Viscosurgical System in Canaloplasty Versus Selective Laser Trabeculoplasty in the Reduction of IOP in Primary Open Angle Glaucoma 73
Table 134: SOLX Inc Pipeline Products & Ongoing Clinical Trials Overview 74
Table 135: SOLX Gold Shunt - Product Status 74
Table 136: SOLX Gold Shunt - Product Description 74
Table 137: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 75
Table 138: Direct Laser Trabeculoplasty System - Product Status 75
Table 139: Direct Laser Trabeculoplasty System - Product Description 75
Table 140: Glaucoma Implant - Product Status 76
Table 141: Glaucoma Implant - Product Description 76
Table 142: TonoGuard Ltd. Pipeline Products & Ongoing Clinical Trials Overview 77
Table 143: EasyIOP - Product Status 77
Table 144: EasyIOP - Product Description 77
Table 145: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 78
Table 146: Aqueous Humor Micro-Bypass Shunt - Product Status 78
Table 147: Aqueous Humor Micro-Bypass Shunt - Product Description 78
Table 148: Glaucoma Device - Product Status 79
Table 149: Glaucoma Device - Product Description 79
Table 150: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 80
Table 151: Integrated Magnetoelastic Actuator - Product Status 80
Table 152: Integrated Magnetoelastic Actuator - Product Description 80
Table 153: University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 81
Table 154: Nanoscale Plates - Product Status 81
Table 155: Nanoscale Plates - Product Description 81
Table 156: University of Rostock Pipeline Products & Ongoing Clinical Trials Overview 82
Table 157: PTX-Eluting Microstent - Product Status 82
Table 158: PTX-Eluting Microstent - Product Description 82
Table 159: Westhouse Medical Services Plc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 83
Table 160: Pneumatic Trabeculoplasty System - Product Status 83
Table 161: Pneumatic Trabeculoplasty System - Product Description 83
Table 162: Glossary 199

1.2 List of Figures
Figure 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development 12
Figure 2: Glaucoma Surgery Devices - Pipeline Products by Segment 13
Figure 3: Glaucoma Surgery Devices - Pipeline Products by Territory 14
Figure 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path 15
Figure 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date 16
Figure 6: Glaucoma Surgery Devices - Ongoing Clinical Trials 17

Companies Mentioned
- Assenti, LLC
- Camras Vision
- Ellex Medical Lasers Limited
- Eye Sonix
- Galaxy Ophthalmics Inc
- Geuder AG
- Glaukos Corp
- iSTAR Medical SA
- Ivantis Inc
- iVeena Delivery Systems Inc
- Johns Hopkins University
- Kytogenics Pharmaceuticals Inc
- Massachusetts Eye and Ear Infirmary
- Medtronic plc
- Meir Medical Center
- Merz Anteis SA
- MicroOptx, Inc.
- Ocumatrx
- OcuTherix Inc
- OPKO Health Inc
- OptoLight Vision Technology
- Queen’s University
- Santen Pharmaceutical Co Ltd
- Sheba Medical Center
- Sight Sciences Inc
- SOLX Inc
- Tel Aviv University
- TonoGuard Ltd.
- University of Colorado
- University of Michigan
- University of Pennsylvania
- University of Rostock
- Westhouse Medical Services Plc